Every year, hundreds of thousands of people worldwide receive the most feared diagnosis in neurology: glioblastoma, the most ...
Researchers headed by teams at Mass General Brigham Cancer Institute and Harvard Medical School have acquired serial biopsies from two recurrent glioblastoma (rGBM) patients who were involved in an ...
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in ...
A UCSF-spun startup backed by Andreessen Horowitz and Y Combinator announced today that it has closed a $9.1 million seed round to advance a genetically engineered virus into its first human clinical ...
SL Science Holding Limited , a biomedical company, last week announced positive preclinical data assessing gamma-omega T cells for treating glioblastoma (GBM). The results were pr ...
PET imaging has become one of the most promising tools for peeking inside glioblastoma, the deadliest adult brain tumor, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results